18 May 2013
Keywords: fda, issues, non-approvable, letter, merck, co, otc
Article | 11 February 2008
The US Food and Drug Administration has issued a non-approvable letter for an over-the-counter formulation of drug major Merck & Co's
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 February 2008
17 May 2013
© 2013 thepharmaletter.com